z-logo
Premium
Posttreatment with Ma‐Xing‐Shi‐Gan‐Tang, a Chinese Medicine Formula, Ameliorates Lipopolysaccharide‐Induced Lung Microvessel Hyperpermeability and Inflammatory Reaction in Rat
Author(s) -
Ma LiQian,
Pan ChunShui,
Yang Ning,
Liu YuYing,
Yan Li,
Sun Kai,
Wei XiaoHong,
He Ke,
Xiao MengMeng,
Fan JingYu,
Han JingYan
Publication year - 2014
Publication title -
microcirculation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 83
eISSN - 1549-8719
pISSN - 1073-9688
DOI - 10.1111/micc.12144
Subject(s) - microvessel , lipopolysaccharide , medicine , traditional chinese medicine , lung , traditional medicine , pathology , angiogenesis , alternative medicine
Objective The aim of present study was to investigate the efficacy of MXSGT , a traditional Chinese medicine formula used for treatment of respiratory system diseases, in the LPS ‐induced rat ALI particularly with a focus on its effect on lung microvascular hyperpermeability and inflammatory reaction. Methods Male Sprague‐Dawley rats were injected with LPS (7.5 mg/kg, 1.5 mg/mL) intraperitoneally. MXSGT (0.52 g or 2.61 g/kg) was given by gavage six hours after LPS injection. Results LPS stimulation resulted in a reduced survival rate, deteriorated vital signs, an increase in the number of leukocytes adhering to lung venules, the albumin leakage, the activity of MPO in lung tissues, the production of pro‐inflammatory cytokines and lung perivascular edema. After LPS stimulation, western blot analysis revealed an increase in the expression of ICAM‐1 and toll‐like receptor 4, a decrease in tight junction proteins and an activation of cav‐1, Src, and NF‐κB. All the LPS ‐induced alterations were significantly attenuated by posttreatment with MXSGT . Conclusions This study demonstrated MXSGT as a potential strategy for lung microvascular hyperpermeability and inflammatory reaction in ALI , and suggested that the beneficial role of MXSGT was correlated with toll‐like receptor 4, Src, and NF‐κB.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here